Results 231 to 240 of about 238,870 (356)

A Model‐Based Meta‐Analysis of Pembrolizumab Effects on Patient‐Reported Quality of Life: Advancing Patient‐Centered Oncology Drug Development

CPT: Pharmacometrics &Systems Pharmacology, EarlyView.
ABSTRACT Pembrolizumab is an immune checkpoint inhibitor that has been approved for more than 20 different indications and has shown great survival benefits in various types of cancer. However, the reported benefits of pembrolizumab in patients' quality of life (QoL) have been inconsistent across different studies and different types of cancer.
Yiqin Zou, Yimeng Sun, Sudhamshu Ravva, Lynne I. Wagner, Jiawei Zhou   +4 more
wiley   +1 more source

Correction: Clinical Burden of Recurrent Disease in High-Risk Endometrial Cancer. [PDF]

Oncol Ther
Kponee-Shovein K, Prabhu VS, Song Y, Chen L, Cheng M, Li Y, Sun Y, Hilts A, Hua Q, Lichfield J, Duska L.   +10 more
europepmc   +1 more source

Endometrial adenosarcoma in the setting of a germline DICER1 mutation: A case report [PDF]

, 2017
Babb, Sheri, Divine, Laura M, Hagemann, Ian S, Mullen, Mary M, Powell, Matthew A   +4 more
core   +3 more sources

Unraveling the Metabolic Influence of Olfactory Receptors in Cancer Cells

Sensory Neuroscience, EarlyView.
ORs are aberrantly expressed in various tumor types and regulate cancer cell metabolism through nonclassical signaling pathways, including PI3K/Akt, MAPK, and ERK. These receptors influence tumor proliferation, invasion, and immune evasion. Specific OR–ligand interactions offer promising opportunities for targeted cancer therapy and early diagnosis ...
Chengzhilin Li, Xiaochen Gao, Ziheng Liu, Nianlei Zhang, Xue Cao, Wenwen Qi, Chengcheng Liu   +6 more
wiley   +1 more source

Calcium Homeostasis Machinery in the Human Uterus-A Potential Therapeutic Target in Endometrial Cancer. [PDF]

Int J Mol Sci
Zakrzewski PK.
europepmc   +1 more source

Endometrial assessment in abnormal uterine bleeding: transvaginal ultrasound alone may not be good enough

Ultrasound in Obstetrics &Gynecology, EarlyView.
ABSTRACT Objective To evaluate the proportion of optimal assessments of endometrial thickness (ET) achieved by transvaginal ultrasound (TVS) compared with a multimodal (MM) sonographic approach in women with abnormal uterine bleeding (AUB). Methods This prospective observational study was a subset of the EPI‐SURE study conducted between June and ...
S. Nijjar, S. Kastora, A. Bajrami, S. Solangon, M. Widschwendter, D. Jurkovic   +5 more
wiley   +1 more source

Women with first recurrence of endometrial cancer: who are they? An analysis of real-world data of the JAGO/NOGGO. [PDF]

BMC Cancer
Proppe L, Zimmermann JSM, Hachenberg J, Pan T, Tsibulak I, Radosa JC, Botscharnikow C, Flethe C, Sehouli J, Pietzner K.   +9 more
europepmc   +1 more source

Ultraprocessed food intake and risk of ovarian and endometrial cancer in the NIH-AARP cohort: a prospective cohort analysis

Caitlin P. O’Connell, Hyokyoung G. Hong, Leila Abar, Neha Khandpur, Carlos Augusto Monteiro, Linda M. Liao, Rashmi Sinha, Britton Trabert, Erikka Loftfield   +8 more
openalex   +2 more sources

Renal cell carcinoma with atypical omental metastasis: A case report and literature review

UroPrecision, EarlyView.
Abstract Background Renal cell carcinoma (RCC) is the most common type of kidney cancer in adults, with common metastatic sites including the lungs, bones, liver, and brain. Omental metastasis is exceedingly rare and usually occurs postoperatively. Fumarate hydratase‐deficient (FH‐deficient) RCC, a recently classified and highly aggressive subtype of ...
Andrew Jing, Zachary Guo, Katherine Wu, Wei Wang, James Jing   +4 more
wiley   +1 more source

Biomarkers and immunotherapy in endometrial cancer: mechanisms and clinical applications. [PDF]

Front Immunol
Zhao L, Li X, Jing Y, Tang L, Lin F, Zhang Y, Tang Y, Chen C, Yang J, Liu X, Chen J.   +10 more
europepmc   +1 more source